Current Trends in Energy Devices – Innovations in Surgery and Tissue Ablation

Application of high-power electrical energy to the body (electrosurgery and radiofrequency ablation) for a variety of beneficial functions has been around for over a century. Applications include general surgical cutting and control of bleeding, tumor destruction and resection, elimination of cardiac arrhythmias, and uterine treatments for fibroids and menorrhagia. We will learn about these different energy types, where and how they are applied, and explore new and exciting innovations.

When:
Jan 6, 2021
5:00 – 7:00 PM (EDT)

Where:
Online
Massachusetts
United States

Contact:
William Munger
wmunger@mdgboston.org
617-620-4161

---

 

Current Trends in Energy Devices

The Latest Innovations for Precise Targeting of:

• Cardiac arrhythmias
• Tumors
• Pelvis disease
• …and more

Wed, Jan 6, 5:00 – 7:00pm (EST)
5:00 – 6:30 Panelist Presentation
6:30 – 7:00 Networking and Meet the Speakers

Forum Fees
$0 – Members (all categories)
$0 – Sponsors / Student
$0 – Covid Hardship
$20 – Non-Member

Overview

For those who want to learn about business opportunities using tissue-targeted, high-powered energies.

Application of high-power electrical energy to the body (electrosurgery and radiofrequency ablation) has been in clinical use for a variety of beneficial treatments.

The types of energies used for tissue modification have expanded over the decades into ultrasound, microwave, freezing, and lasers. Some applications include general surgical cutting and control of bleeding, tumor destruction and resection, elimination of cardiac arrhythmias.

We will learn about these different energy types, where and how they are applied, and explore new and exciting innovations

 

---

 

PANELISTS

Aditi Ray, PhD
Principal Scientist, Boston Scientific

Dr. Ray is an R&D Fellow at Boston Scientific’s Urology and Pelvic Health division.

 

 

Sebastian Flacke, MD
Chief, Interventional Radiology, Lahey Hospital/Medical Center

Dr. Flacke’s main clinical focus is minimal invasive cancer treatment with a focus on liver disease.

 

 

Muneeb Ahmed, MD
Chief, Division of Vascular and Interventional Radiology, Beth Israel Medical Center

Dr. Ahmed directs the NIH-funded Minimally Invasive Tumor Therapy Laboratory, which studies tumor ablation biology, targeted drug delivery, and more

 

MODERATOR & CO-CHAIR

Alan Oslan, MS, MBA
President and Founder, ElectroSurge

Alan has extensive experience in devices for electrosurgery and radiofrequency ablation.

 

CO-CHAIR

Geoff Moodie, PhD
Director, Biocompatibility, Eurofins VP, Programming at MDG Boston and Board Member

Alan has extensive experience in devices for electrosurgery and radiofrequency ablation.

 

 

 

---

 

January 6, 2021 Forum